A pre-print is sending the biotech's shares higher today.
News & Analysis: Heat Biologics
Reports of an early approval for AstraZeneca's COVID-19 vaccine are sending these three stocks lower today.
Encouraging early results for the biotech's coronavirus vaccine have investors excited.
Major new developments in the race for a COVID-19 vaccine are driving investors to reevaluate their positions.
Russia's surprise vaccine announcement isn't sitting well with shareholders of Dynavax, Heat Biologics, or Inovio Pharmaceuticals.
Heat Biologics and Vaxart could have a lot more room to run.
The biotech's COVID-19 vaccine candidate hit the mark in a preclinical study.